The control of elemental impurities is a critical step in the preparation of lanthanum carbonate, with platinum being one such impurity. Residual platinum is typically non-therapeutic and must be strictly controlled to ensure both safety and product quality. This paper describes a colorimetric method for determining platinum (IV) in solutions based on the anti-aggregation of gold nanoparticles modified with 4-methylsulfonylaniline (4-MESA). The presence of Britton–Robinson buffer induces the aggregation of the 4-MESA-AuNPs nanoparticle probe. However, when platinum (IV) is introduced, it disrupts the aggregation of the 4-MESA-AuNPs, causing a color change in the solution. The absorbance at 524 nm showed a strong linear correlation in the concentration range of 1.00 × 10−2 μM to 5.00 × 102 μM. Under optimal conditions, LOD and LOQ values of 10.00 × 10−3 μM and 3.03 × 10−2 μM, respectively, were observed. This method has been successfully applied to the determination of platinum (IV) in lanthanum carbonate API.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: